Clinical Trial Detail

NCT ID NCT02423954
Title Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Western Regional Medical Center
Indications

Advanced Solid Tumor

Therapies

Temsirolimus

Nivolumab

Capecitabine

Irinotecan

Age Groups: adult

No variant requirements are available.